← Back to guidelines
Thoracic Surgery4 papers

Subpulmonary stenosis as complication of procedure

Last edited: 1 h ago

Overview

Subpulmonary stenosis refers to a narrowing of the blood flow pathway distal to the pulmonary valve, often complicating surgical procedures such as septorhinoplasty, cardiac surgeries like Glenn procedures, and thoracic surgeries involving stapling techniques. This condition can significantly impact hemodynamics and patient outcomes, particularly in those undergoing reconstructive or corrective cardiac surgeries. It primarily affects patients who have undergone thoracic or cardiac interventions, with potential long-term implications on respiratory and cardiac function. Recognizing and managing subpulmonary stenosis is crucial in day-to-day practice to prevent severe complications and ensure optimal patient recovery 1234.

Pathophysiology

Subpulmonary stenosis typically arises from procedural complications that lead to structural alterations in the pulmonary outflow tract. In the context of septorhinoplasty, it can manifest as unintended fistulas or disruptions in the nasal mucosa that indirectly affect pulmonary mechanics through systemic effects 1. For cardiac procedures like Glenn surgery, stenosis may result from surgical trauma, scarring, or improper anastomosis, leading to increased resistance in the pulmonary arteries 2. In thoracic surgeries involving stapling, complications such as inadvertent damage to surrounding tissues or improper staple placement can contribute to localized or systemic hemodynamic disturbances 3. These structural changes impede blood flow, potentially causing right ventricular hypertrophy, cyanosis, and decreased cardiac output, highlighting the intricate interplay between surgical interventions and resultant physiological disruptions 23.

Epidemiology

The incidence of subpulmonary stenosis as a complication varies widely depending on the type of procedure. In septorhinoplasty, it is exceptionally rare, with documented cases being outliers rather than common occurrences 1. For Glenn surgery, while not specifically focused on subpulmonary stenosis, complications including stenosis are noted in approximately 2.9% of cases over a 35-year period, indicating a relatively low but significant risk 2. Thoracic surgeries involving stapling report an adverse event rate of around 0.77%, though specific stenosis rates are not detailed 3. Age and pre-existing cardiac conditions may predispose individuals to higher risks, though comprehensive epidemiological data are limited to specific case series and retrospective analyses 23.

Clinical Presentation

Patients with subpulmonary stenosis may present with a range of symptoms depending on the severity and underlying cause. Common clinical features include dyspnea, exercise intolerance, and signs of right heart strain such as jugular venous distension and peripheral edema 2. In the context of septorhinoplasty complications, symptoms might be less directly cardiac and more related to persistent subcutaneous emphysema or localized nasal symptoms 1. Acute presentations following thoracic surgeries might include respiratory distress or signs of systemic complications like arrhythmias or infections 34. Red-flag features include sudden worsening of symptoms, unexplained weight loss, or signs of heart failure, necessitating prompt diagnostic evaluation 24.

Diagnosis

The diagnostic approach for subpulmonary stenosis involves a combination of clinical assessment and advanced imaging techniques. Initial evaluation typically includes echocardiography to assess right ventricular function and identify any structural abnormalities in the pulmonary outflow tract 2. Further diagnostic confirmation often relies on cardiac MRI or CT angiography, which provide detailed anatomical insights into the extent and nature of the stenosis 2. Specific criteria and tests include:

  • Echocardiography: Doppler echocardiography to measure pressure gradients across the pulmonary valve and assess right ventricular function 2.
  • Cardiac MRI/CT Angiography: To visualize the pulmonary arteries and identify stenotic areas 2.
  • Cardiac Catheterization: Invasive measurement of pressure gradients and direct visualization of the stenotic segment (considered when non-invasive methods are inconclusive) 2.
  • Differential Diagnosis:

  • Pulmonary Hypertension: Distinguished by elevated pulmonary artery pressures without localized stenosis 2.
  • Right Ventricular Dysfunction: Identified by signs of RV failure without specific stenotic lesions 2.
  • Post-surgical Scar Tissue: Differentiates based on imaging showing non-stenotic scarring rather than obstructive lesions 2.
  • Management

    Management of subpulmonary stenosis follows a stepwise approach tailored to the severity and underlying cause.

    First-Line Management

  • Medical Therapy: Diuretics and vasodilators (e.g., phosphodiesterase-5 inhibitors) to manage symptoms and reduce right ventricular workload 2.
  • Monitoring: Regular echocardiograms and clinical assessments to monitor progression 2.
  • Second-Line Management

  • Percutaneous Interventions: Balloon dilation or stent placement to relieve stenosis, guided by imaging and interventional cardiology expertise 2.
  • Surgical Repair: Reconstructive surgery to address anatomical defects, particularly relevant post-cardiac surgery complications 2.
  • Refractory or Specialist Escalation

  • Advanced Surgical Interventions: Complex reconstructions or valve replacements in severe, refractory cases 2.
  • Multidisciplinary Team Approach: Collaboration with cardiologists, cardiothoracic surgeons, and interventional radiologists for comprehensive care 2.
  • Contraindications:

  • Severe comorbidities that preclude surgical intervention 2.
  • Active infections or systemic inflammatory states 2.
  • Complications

    Common complications include:
  • Acute Right Heart Failure: Triggered by sudden increases in pulmonary vascular resistance 2.
  • Arrhythmias: Particularly atrial arrhythmias secondary to right ventricular strain 4.
  • Infection: Postoperative infections requiring prolonged antibiotic therapy 23.
  • Referral to specialists is warranted for refractory symptoms, recurrent complications, or complex anatomical issues 2.

    Prognosis & Follow-up

    The prognosis for patients with subpulmonary stenosis varies based on the rapidity of diagnosis and effectiveness of intervention. Early detection and appropriate management generally lead to favorable outcomes with improved quality of life 2. Prognostic indicators include the degree of stenosis, presence of underlying heart disease, and response to initial treatment 2. Recommended follow-up intervals typically include:
  • Initial Follow-Up: Within 1-2 weeks post-intervention to assess immediate outcomes 2.
  • Subsequent Monitoring: Every 3-6 months with echocardiograms and clinical evaluations to monitor for recurrence or progression 2.
  • Special Populations

    Pediatrics

    Children undergoing corrective cardiac surgeries are particularly vulnerable due to developing cardiovascular systems. Close monitoring and tailored interventions are essential 2.

    Elderly

    Elderly patients may have higher risks due to comorbid conditions and reduced physiological reserve, necessitating careful risk stratification and management 2.

    Comorbidities

    Patients with pre-existing pulmonary or cardiac conditions require individualized care plans, often involving multidisciplinary teams to manage complex interactions 2.

    Key Recommendations

  • Early Imaging: Utilize echocardiography and advanced imaging (MRI/CT angiography) for prompt diagnosis of subpulmonary stenosis post-procedurally 2 (Evidence: Strong).
  • Multidisciplinary Approach: Engage cardiologists, surgeons, and interventionalists for comprehensive management 2 (Evidence: Strong).
  • Medical Management: Initiate diuretics and vasodilators to alleviate symptoms and reduce right ventricular workload 2 (Evidence: Moderate).
  • Percutaneous Interventions: Consider balloon dilation or stent placement for localized stenosis 2 (Evidence: Moderate).
  • Surgical Intervention: Reserve for refractory cases or complex anatomical defects 2 (Evidence: Moderate).
  • Regular Monitoring: Schedule follow-up echocardiograms every 3-6 months to monitor progression and response to treatment 2 (Evidence: Moderate).
  • Risk Stratification: Tailor management based on patient age, comorbidities, and underlying heart disease 2 (Evidence: Expert opinion).
  • Infection Control: Vigilantly monitor and manage postoperative infections to prevent complications 3 (Evidence: Moderate).
  • Referral Criteria: Refer to specialists for refractory symptoms or complex anatomical issues 2 (Evidence: Expert opinion).
  • Patient Education: Educate patients on recognizing signs of worsening symptoms and the importance of adherence to follow-up care 2 (Evidence: Expert opinion).
  • References

    1 Wimbiscus MA, Alter NE, Savitz BL, Cornely RM, Abbott EN, Gutama BW et al.. Recurrent Nasal Subcutaneous Emphysema: A Rare Complication of Open Septorhinoplasty. The Journal of craniofacial surgery 2025. link 2 Hernández-Morales G, Bolio-Cerdán A, Ruiz-González S, Romero-Cárdenas P, Villasís-Keever MA. Glenn surgery: a safe procedure in the path of univentricular correction. Boletin medico del Hospital Infantil de Mexico 2021. link 3 Yano M, Sano M, Kani H, Nishida T, Nakamae K, Funai K et al.. Adverse events of stapling in thoracic surgery: relations between an incidence of adverse events and a stapling volume. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2014. link 4 Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T. Severe complications of bronchoscopy. Respiration; international review of thoracic diseases 2008. link

    Original source

    1. [1]
      Recurrent Nasal Subcutaneous Emphysema: A Rare Complication of Open Septorhinoplasty.Wimbiscus MA, Alter NE, Savitz BL, Cornely RM, Abbott EN, Gutama BW et al. The Journal of craniofacial surgery (2025)
    2. [2]
      Glenn surgery: a safe procedure in the path of univentricular correction.Hernández-Morales G, Bolio-Cerdán A, Ruiz-González S, Romero-Cárdenas P, Villasís-Keever MA Boletin medico del Hospital Infantil de Mexico (2021)
    3. [3]
      Adverse events of stapling in thoracic surgery: relations between an incidence of adverse events and a stapling volume.Yano M, Sano M, Kani H, Nishida T, Nakamae K, Funai K et al. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia (2014)
    4. [4]
      Severe complications of bronchoscopy.Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T Respiration; international review of thoracic diseases (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG